PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 122 filers reported holding PMV PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $209,196 | -44.3% | 34,071 | -43.2% | 0.00% | 0.0% |
| Q2 2023 | $375,694 | -42.5% | 60,015 | -56.2% | 0.00% | -50.0% |
| Q1 2023 | $653,252 | +436.3% | 136,950 | +878.2% | 0.00% | – |
| Q4 2022 | $121,800 | -64.0% | 14,000 | -50.7% | 0.00% | -100.0% |
| Q3 2022 | $338,000 | -63.9% | 28,400 | -36.7% | 0.00% | -66.7% |
| Q1 2022 | $935,000 | -85.1% | 44,900 | -83.5% | 0.00% | -76.9% |
| Q4 2021 | $6,273,000 | +1352.1% | 271,546 | +1772.7% | 0.01% | +1200.0% |
| Q3 2021 | $432,000 | – | 14,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $23,012,000 | 42.78% |
| Euclidean Capital LLC | 2,336,909 | $33,301,000 | 28.32% |
| OUP Management Co., LLC | 989,232 | $14,097,000 | 19.40% |
| Nextech Invest Ltd. | 1,385,807 | $19,748,000 | 6.66% |
| Boxer Capital, LLC | 3,498,636 | $49,856,000 | 3.16% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $7,842,000 | 1.84% |
| Orbimed Advisors | 6,563,077 | $93,524,000 | 1.70% |
| RTW INVESTMENTS, LP | 4,395,677 | $62,638,000 | 1.62% |
| ACUTA CAPITAL PARTNERS, LLC | 152,500 | $2,173,000 | 1.21% |
| Avoro Capital Advisors LLC | 3,100,000 | $44,175,000 | 0.87% |